Structural investigations isomeric oxidised forms of hyperforin by HPLC-NMR and HPLC-MSn

Phytochemical Analysis

Volumn 14, Issue 5, 2003, Pages 290-297

  Wolfender, J L ^a   Verotta, L ^b   Belvisi, L ^b   Fuzzati, N ^c   Hostettmann, Kurt ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b UNIVERSITY OF MILAN   (Italy)

^c INDENA S P A   (Italy)

Author keywords

HPLC MS; HPLC NMR; Hypericaceae; Hypericum perforatum; Oxidised forms of hyperforin

Indexed keywords

DEGRADATION;

HPLC-MS; HPLC-NMR; HYPERFORINS; HYPERICACEAE; HYPERICUM PERFORATUM; OXIDATIVE DEGRADATION; OXIDIZED FORM OF HYPERFORIN; PHLOROGLUCINOL; ST JOHN'S WORT; STRUCTURAL INVESTIGATION;

OXIDATION;

ANTIDEPRESSANT AGENT; HEXANE; HYPERFORIN; HYPERICUM PERFORATUM EXTRACT; PHLOROGLUCINOL DERIVATIVE;

ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG ACTIVITY; DRUG DEGRADATION; DRUG IDENTIFICATION; DRUG ISOLATION; DRUG OXIDATION; DRUG STABILITY; DRUG STORAGE; DRUG STRUCTURE; FLOW KINETICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOMER; MASS SPECTROMETRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ONLINE SYSTEM; PRENYLATION; ROOM TEMPERATURE; SOLUBILITY; STANDARDIZATION; STRUCTURE ANALYSIS;

CLUSIACEAE; HYPERICUM; HYPERICUM PERFORATUM;

EID: 0141453786     PISSN: 09580344     EISSN: None     Source Type: Journal    
DOI: 10.1002/pca.718     Document Type: Article

References (25)

1. Albert K, Dachtler M, Glaser T, Händel H, Lacker G, Schlotterbeck G, Strohschein S, Tseng, LH. 1999. On-line coupling of separation techniques to NMR. J High Resol Chromatogr 22: 135-143.
2. Albert D, Zündorf I, Dingermann T, Müller WE, Steinhilber D, Werz O. 2002. Hyperforin is a dual inhibitor of cyclooxygenase-1 and 5-lipoxygenase. Biochem Pharmac 64: 1767-1775.
3. Allinger NL. 1977. Conformational analysis. 130. MM2. A hydrocarbon force field utilizing V1 and V2 torsional terms. J Am Chem Soc 99: 8127-8134.
4. Bilia AR, Bergonzi MC, Morgenni F, Mazzi G, Vinceri FF. 2001. Evaluation of chemical stability of St. John's Wort commercial extract and some preparations. Int J Pharm 213: 199-208.
5. Butterweck V, Nahrstedt A, Evans J, Hufeisen S, Rauser L, Savage J, Popadak S, Ernsberger P, Roth BL. 2002. In vitro receptor screening of pure constituents of St. John's Wort reveals novel interactions with a number of GPCRs. Psychopharmacology 162: 193-202.
6. 1H NMR for the study of an anti-oxidant fraction from Orophea enneandra and isolation of a polyacetylene, lignans and a tocopherol derivative. J Nat Prod 61: 1497-1501.
7. Chang G, Guida WC, Still WC. 1989. An internal-coordinate Monte Carlo method for searching conformational space. J Am Chem Soc 111: 4379-4386.
8. Fiebich BL, Heinrich M, Langosh JM, Kammerer N, Lieb K. 1999. Anti-bacterial activity of hyperforin from St. John's Wort. Lancet 354: 777.
9. Fukuyama Y, Minami H, Kuwayama A. 1998. Garsubellins, polyisoprenylated phloroglucinol derivatives from Garcinia subelliptica. Phytochemistry 49: 853-857.
10. Fuzzati N, Gabetta N, Strepponi I, Villa F. 2001. High-performance liquid chromatography-electrospray ionisation mass spectrometry and multiple mass spectrometry studies of hyperforin degradation products. J Chromatogr A 926: 187-198.
11. Gobbi M, Dalla Valle F, Ciapparelli C, Diomede L, Morazzoni P, Verotta L, Mennini T. 1999. Hypericum perforatum extract does not inhibit 5-HT transporter in rat brain cortex. Naunyn-Schmiedeberg's Arch Pharmacol 360: 262-269.
12. Mohamadi F, Richards NGJ, Guida WC, Liskamp R, Lipton M, Caufield C, Chang G, Hendrickson T, Still WC. 1990. MacroModel-An integrated software system for modelling organic and bioorganic molecules using molecular mechanics. J Comput Chem 11: 440-467.
13. Moore LB, Goodwin B, Jones SA, Wisely GB, Serabit-Singh CJ, Wilson TM, Collins JL, Kliewer SA. 2000. St. John's Wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc Natl Acad Sci USA 97: 7500-7502.
14. Müller WE, Singer A, Wonnemann M. 2001. Hyperforin-antidepressant activity by a novel mechanism of action. Pharmacopsychiatry 34 Suppl. 1: S98-S102.
15. Orth HCJ, Rentel C, Schmidt PC. 1999. Isolation, purity analysis and stability of hyperforin as a standard material from Hypericum perforatum L. J Pharm Pharmac 51: 193-200.
16. Ponder JW, Richards FM. 1987. An efficient Newton-like method for molecular mechanics energy minimisation of large molecules. J Comput Chem 8: 1016-1024.
17. Roz N, Mazur Y, Hirshfeld A, Rehavi M. 2002. Inhibition of vesicular uptake of monoamines by hyperforin. Life Sci 71: 2227-2237.
18. Schempp CM, Kirkin V, Simon-Haarhaus B, Kersten A, Kiss CC, Gilb B, Kaufmann T, Borner, C, Sleeman JP, Simon JC. 2002. Inhibition of tumour cell growth by hyperforin, a novel anticancer drug from St. John's Wort that acts by induction of apoptosis. Oncogene 21: 1242-1250.
19. Smallcombe SH, Patt SL, Keiffer PA. 1995. WET solvent suppression and its application to LC-NMR and high-resolution NMR spectroscopy. J Magn Reson Ser A 117: 295-303.
20. Still WC, Tempczyk A, Hawley RC, Hendrickson T. 1990. Semi-analytical treatment of solvation for molecular mechanics and dynamics. J Am Chem Soc 112: 6127-6129.
21. Trifunovic S, Vajs V, Macura S, Juranic N, Djarmati N, Jankov R, Milosavljevic S. 1998. Oxidation products of hyperforin from Hypericum perforatum. Phytochemistry 49: 1305-1310.
22. Verotta L, Appendino G, Belloro E, Jakupovic J, Bombardelli E. 1999. Furohyperforin, a prenylated phloroglucinol from St. John's Wort (Hypericum perforatum). J Nat Prod 62: 770-772.
23. Verotta L, Appendino G, Belloro E, Jakupovic J, Bombardelli E. 2000. Hyperforin analogues from St. John's Wort (Hypericum perforatum). J Nat Prod 63: 412-415.
24. Verotta L, Appendino G, Belloro E, Bianchi F, Sterner O, Lovati M, Bombardelli E. 2002. Synthesis and biological evaluation of hyperforin analogues. Part I. Modification of the enolised cyclohexanedione moiety. J Nat Prod 65: 433-438.
25. Wolfender JL, Ndjoko K, Hostettmann K. 2001. The potential of LC-NMR in phytochemical analysis. Phytochem Anal 12: 2-22.